Publications

5891 Results

"Neo-FAC" (5-fluorouracil, doxorubicin and cyclophosphamide) for poor prognosis stage IV breast cancer: A Southwest Oncology Group Phase II study.

Authors
GK Ellis;S Green;RB Livingston;MJ Kraut;HI Pierce;JC Paradelo;SA Taylor;S Martino
Journal / Conference
American Journal of Clinical Oncology 22(5):446-449
Year
1999
Research Committee(s)
Breast
Study Number(s)
SWOG-8923

Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study

Authors
JA Kish;JK Benedetti;SP Balcerzak;RW Veith;R Davis;TW Pollock;DE Schuller;JF Ensley
Journal / Conference
Cancer Journal from Scientific American 5(5):307-311
Year
1999
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8957

Cis-platinum, methotrexate, and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study.

Authors
GP Haas;M Wolf;RG Gagliano;CA Russell;SE Rivkin;BA Blumenstein;ED Crawford
Journal / Conference
Journal of Urology 161:1823-1825
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8520

Inclusion of black americans in oncology clinical trials: the Louisiana State University medical center experience.

Authors
RF Holcombe;J Jacobson;A Li;CM Moinpour
Journal / Conference
American Journal of Clinical Oncology 22(1):18-21
Year
1999
Research Committee(s)
Cancer Control

Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.

Authors
Q Li;KJ Kopecky;A Mohan;CL Willman;FR Appelbaum;JK Weick;JJ Issa
Journal / Conference
Clinical Cancer Research 5:1077-1084
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Association of immune parameters with clinical outcome in stage III colon cancer: Results of Southwest Oncology Group Protocol 9009.

Authors
RF Holcombe;J Jacobson;SR Dakhil;RM Stewart;KS Betzing;K Kannan;JS Macdonald
Journal / Conference
Cancer Immunology and Immunotherapy 48:533-539
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9009

A phase II evaluation of all trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: A Southwest Oncology Group study.

Authors
VK Sondak;PY Liu;LE Flaherty;WS Fletcher;P Periman;DR Gandara;SA Taylor;SP Balcerzak;FL Meyskens, Jr.
Journal / Conference
Cancer Journal from Scientific American 5(1):41-47
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9223

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study.

Authors
CW Whitney;W Sause;BN Bundy;JH Malfetano;EV Hannigan;WC Fowler Jr;DL Clarke-Pearson;S Liao
Journal / Conference
Journal of Clinical Oncology 17(5):1339-1348
Year
1999
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8695

Treatment of poor prognosis extensive disease small cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - A Southwest Oncology Group clinical and pharmacokinetic study.

Authors
SM Grunberg;JJ Crowley;KR Hande;DJ Giroux;NC Munshi;DHM Lau;LE Schroder;MH Zangmeister;SP Balcerzak;HE Hynes;DR Gandara
Journal / Conference
Cancer Chemotherapy and Pharmacology 44:461-468
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9307

p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.

Authors
DM Tolbert;AE Noffsinger;MA Miller;GW DeVoe;GN Stemmermann;JS Macdonald;CM Fenoglio-Preiser
Journal / Conference
Modern Pathology 12(1):54-60
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)